POMALIDOMID Zentiva caps 3 mg 21 pce
7680690570064
CH-69057
L04AX06
07.16.4.
Reimbursement limitations:
POMALI.Ze.01
Association d’POMALIDOMID ZENTIVA avec élotuzumab et la dexaméthasone
Après la garantie de prise en charge …
1 / 3
google
Details
- Product number
- 6905703
- CPT
- -
- Packaging group
- 21
- Unit
- Kapsel(n)
- Composition
- pomalidomidum 3 mg, cellulosum microcristallinum, maltodextrinum, natrii stearylis fumaras, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), E 132, Drucktinte: lacca, E 171, pro capsula corresp. natrium 0.021 mg.
Articles (1)
Pomalidomid Zentiva 3 mg, Hartkapseln
Kapseln
21
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
3.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
0.021 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 3504.45
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/08/2024
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 69057
- Drug name
- Pomalidomid Zentiva, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L04AX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 03/06/2024
- Authorization expiration date
- 02/06/2029
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- POMALIDOMID Zentiva caps 3 mg 21 pce
- Description (DE)
- POMALIDOMID Zentiva Kaps 3 mg 21 Stk
- Market launch
- 03/06/2024
- Narcotic (BTM)
- No